Literature DB >> 24001752

Elucidating binding modes of zuonin A enantiomers to JNK1 via in silico methods.

Daniel W Dykstra1, Kevin N Dalby, Pengyu Ren.   

Abstract

Aberrant c-Jun N-terminal kinase (JNK) signaling is associated with a number of diseases, including neurological conditions and cancer. Enantiomers of the lignan zuonin A, (-)-zuonin A and (+)-zuonin A bind isoforms of JNK with similar affinity and disrupt protein-protein interactions at JNK's D-recruitment site. Thus, they are of interest as lead non-ATP competitive inhibitors of the JNKs. While (-)-zuonin A inhibits the activity of JNK toward c-Jun by 80% when saturating, (+)-zuonin A only inhibits by 15%. Molecular docking and molecular dynamics simulations were performed to gain a better understanding of how these inhibitors interact with JNK. The results of this study provide new insight into potential binding modes for (-)-zuonin A and suggest that (-)-zuonin A interacts with JNK via an induced fit mechanism near the highly conserved φA-X-φB recognition site. Binding of (+)-zuonin A to JNK displays no such dynamic feature. The different binding modes may help explain differences in the inhibitory properties of the enantiomers although further experimental work would be necessary to fully confirm this interpretation.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Docking; JNK; Kinase; MAPK; Molecular dynamics; Non-ATP competitive inhibitor

Mesh:

Substances:

Year:  2013        PMID: 24001752      PMCID: PMC3804409          DOI: 10.1016/j.jmgm.2013.08.008

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  10 in total

1.  Diverse, high-quality test set for the validation of protein-ligand docking performance.

Authors:  Michael J Hartshorn; Marcel L Verdonk; Gianni Chessari; Suzanne C Brewerton; Wijnand T M Mooij; Paul N Mortenson; Christopher W Murray
Journal:  J Med Chem       Date:  2007-02-22       Impact factor: 7.446

Review 2.  The c-jun kinase/stress-activated pathway: regulation, function and role in human disease.

Authors:  Gary L Johnson; Kazuhiro Nakamura
Journal:  Biochim Biophys Acta       Date:  2007-01-04

3.  Virtual screening using molecular simulations.

Authors:  Tianyi Yang; Johnny C Wu; Chunli Yan; Yuanfeng Wang; Ray Luo; Michael B Gonzales; Kevin N Dalby; Pengyu Ren
Journal:  Proteins       Date:  2011-04-12

4.  Understanding the specificity of a docking interaction between JNK1 and the scaffolding protein JIP1.

Authors:  Chunli Yan; Tamer Kaoud; Sunbae Lee; Kevin N Dalby; Pengyu Ren
Journal:  J Phys Chem B       Date:  2011-01-25       Impact factor: 2.991

5.  Mitogen-activated protein kinase (MAPK)-docking sites in MAPK kinases function as tethers that are crucial for MAPK regulation in vivo.

Authors:  S Grewal; D M Molina; L Bardwell
Journal:  Cell Signal       Date:  2005-06-24       Impact factor: 4.315

6.  Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125.

Authors:  Yong-Seok Heo; Su-Kyoung Kim; Chang Il Seo; Young Kwan Kim; Byung-Je Sung; Hye Shin Lee; Jae Il Lee; Sam-Yong Park; Jin Hwan Kim; Kwang Yeon Hwang; Young-Lan Hyun; Young Ho Jeon; Seonggu Ro; Joong Myung Cho; Tae Gyu Lee; Chul-Hak Yang
Journal:  EMBO J       Date:  2004-05-13       Impact factor: 11.598

7.  From in Silico Discovery to intra-Cellular Activity: Targeting JNK-Protein Interactions with Small Molecules.

Authors:  Tamer S Kaoud; Chunli Yan; Shreya Mitra; Chun-Chia Tseng; Jiney Jose; Juliana M Taliaferro; Maidina Tuohetahuntila; Ashwini Devkota; Rachel Sammons; Jihyun Park; Heekwang Park; Yue Shi; Jiyong Hong; Pengyu Ren; Kevin N Dalby
Journal:  ACS Med Chem Lett       Date:  2012-08-06       Impact factor: 4.345

8.  Manipulating JNK signaling with (--)-zuonin A.

Authors:  Tamer S Kaoud; Heekwang Park; Shreya Mitra; Chunli Yan; Chun-Chia Tseng; Yue Shi; Jiney Jose; Juliana M Taliaferro; Kiyoun Lee; Pengyu Ren; Jiyong Hong; Kevin N Dalby
Journal:  ACS Chem Biol       Date:  2012-08-30       Impact factor: 5.100

9.  Non-ATP competitive protein kinase inhibitors as anti-tumor therapeutics.

Authors:  Lindsay O Kirkland; Campbell McInnes
Journal:  Biochem Pharmacol       Date:  2009-01-10       Impact factor: 5.858

Review 10.  Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies.

Authors:  Clare Davies; Cathy Tournier
Journal:  Biochem Soc Trans       Date:  2012-02       Impact factor: 5.407

  10 in total
  1 in total

1.  Antileishmanial Activity of Lignans, Neolignans, and Other Plant Phenols.

Authors:  Jiří Pospíšil; Daniela Konrádová; Miroslav Strnad
Journal:  Prog Chem Org Nat Prod       Date:  2021
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.